Stockreport

Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients [Yahoo! Finance]

Clene Inc.  (CLNN) 
PDF Across non-active progressive MS (primary progressive and secondary progressive MS), relapsing MS, and Parkinson's disease patients, CNM-Au8 ® improved the brain's ener [Read more]